Drugs / Geranium wilfordii
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT06861166 Comparator | Mar 2025 → Mar 2026 overdue | prostate cancer | baotai Liang | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Geranium wilfordii | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06861166 ↗ |
| Route | Oral | “was taken orally” NCT06861166 ↗ |